PRO ACTIVE REGULAR DOSING Trademark

Trademark Overview

On Monday, July 26, 2021, a trademark application was filed for PRO ACTIVE REGULAR DOSING with the United States Patent and Trademark Office. The USPTO has given the PRO ACTIVE REGULAR DOSING trademark a serial number of 90848331. The federal status of this trademark filing is REGISTERED as of Tuesday, November 22, 2022. This trademark is owned by Glaxo Group Limited. The PRO ACTIVE REGULAR DOSING trademark is filed in the Education & Entertainment Services category with the following description:

Conducting educational support programs for health care providers and patients; Educational and training services, namely, training of health care providers relating to the prevention, treatment, and alleviation of respiratory diseases and disorders
pro active regular dosing

General Information

Serial Number90848331
Word MarkPRO ACTIVE REGULAR DOSING
Filing DateMonday, July 26, 2021
Status700 - REGISTERED
Status DateTuesday, November 22, 2022
Registration Number6904407
Registration DateTuesday, November 22, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 6, 2022

Trademark Statements

Goods and ServicesConducting educational support programs for health care providers and patients; Educational and training services, namely, training of health care providers relating to the prevention, treatment, and alleviation of respiratory diseases and disorders

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateFriday, September 24, 2021
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Tuesday, November 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 7, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 7, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 22, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 22, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 6, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 6, 2022PUBLISHED FOR OPPOSITION
Wednesday, August 17, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 29, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 19, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 19, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 18, 2022ASSIGNED TO LIE
Wednesday, June 29, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, March 11, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, March 11, 2022LETTER OF SUSPENSION E-MAILED
Friday, March 11, 2022SUSPENSION LETTER WRITTEN
Friday, March 11, 2022EXAMINER'S AMENDMENT ENTERED
Friday, March 11, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 11, 2022EXAMINERS AMENDMENT E-MAILED
Friday, March 11, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 8, 2022ASSIGNED TO EXAMINER
Friday, September 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 29, 2021NEW APPLICATION ENTERED

Related Keywords

dosing regular active care providers health training educational alleviation treatment respiratory diseases disorders